Core Scientific's (CORZ) shares drop after Q4 2025 results show lower revenue than expected, plus a restatement of past financials due to overstated assets—no impact on key metrics like sales or cash flow.
BTIG upgraded Core Scientific to Buy with a $23 target, citing improved prospects after the CoreWeave merger rejection and strong demand for high-performance computing power.
Citigroup forecasts bitcoin reaching $143,000 and ethereum $4,304 within 12 months, citing regulatory improvements and growing adoption despite recent market volatility.
Citizens analyst Greg Miller upgrades Core Scientific to Outperform, citing strong growth, HPC demand, and strategic focus after CoreWeave deal setback.
Core Scientific shareholders rejected the merger with AI company CoreWeave. The deal is terminated, but their business partnership continues.
B. Riley raises Core Scientific price target to $30, predicting shareholders will vote down CoreWeave's $9B offer. Glass Lewis and ISS recommend voting against.
